Skip to main content

Table 1 Prevalence and demographic characteristics of triptan users and unmet medical needs (UMN) in migraineurs treated with triptans, for the overall cohort and stratified for subtypes according to the average triptan dose units per month

From: A real-world study on unmet medical needs in triptan-treated migraine: prevalence, preventive therapies and triptan use modification from a large Italian population along two years

  Overall triptan users Overall UMN migraineurs Average triptan dose units per month in 1 year
4–9 10–14 > 14
pLF-EM pHF-EM pCM
  82,446 31,515 22,796 5467 3252
Rate of triptan users (%) 100 38.2 27.6 6.6 3.9
Rate of UMN migraineurs (%) 100 72.3 17.4 10.3
Prevalence (per 1000 adult inhabitants) 8.0 3.1 2.2 0.5 0.3
Gender
 Female (%) 78.5 80.9 81.5 81.0 76.2
 Male (%) 21.5 19.1 18.4 19.0 23.8
Age
 Mean ± SD 47 ± 13 49 ± 11 48 ± 11 49 ± 11 50 ± 11
 Median 47 48 48 48 49
 18–29 (%) 9.8 5.0 5.5 3.6 4.0
 30–39 (%) 18.0 14.4 15.8 14.0 12.1
 40–49 (%) 32.0 36.2 33.0 37.1 35.4
 50–59 (%) 24.1 28.6 27.7 29.5 29.8
 60–69 (%) 10.9 11.7 13.5 11.5 13.0
 70–79 (%) 3.9 3.5 3.9 3.5 4.8
 ≥ 80 (%) 1.2 0.7 0.6 1.0 0.8
  1. UMN Unmet medical need, pLF-EM Possible low frequency episodic migraine, pHF-EM Possible high frequency episodic migraine, pCM Possible chronic migraine
\